BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 22304930)

  • 1. Congenital disorder of glycosylation type Ij (CDG-Ij, DPAGT1-CDG): extending the clinical and molecular spectrum of a rare disease.
    Würde AE; Reunert J; Rust S; Hertzberg C; Haverkämper S; Nürnberg G; Nürnberg P; Lehle L; Rossi R; Marquardt T
    Mol Genet Metab; 2012 Apr; 105(4):634-41. PubMed ID: 22304930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of UDP-GlcNAc:Dolichol Phosphate N-Acetylglucosamine-1 Phosphate Transferase (DPAGT1) causes a novel congenital disorder of Glycosylation Type Ij.
    Wu X; Rush JS; Karaoglu D; Krasnewich D; Lubinsky MS; Waechter CJ; Gilmore R; Freeze HH
    Hum Mutat; 2003 Aug; 22(2):144-50. PubMed ID: 12872255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALG1-CDG: a new case with early fatal outcome.
    Rohlfing AK; Rust S; Reunert J; Tirre M; Du Chesne I; Wemhoff S; Meinhardt F; Hartmann H; Das AM; Marquardt T
    Gene; 2014 Jan; 534(2):345-51. PubMed ID: 24157261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy.
    Barone R; Aiello C; Race V; Morava E; Foulquier F; Riemersma M; Passarelli C; Concolino D; Carella M; Santorelli F; Vleugels W; Mercuri E; Garozzo D; Sturiale L; Messina S; Jaeken J; Fiumara A; Wevers RA; Bertini E; Matthijs G; Lefeber DJ
    Ann Neurol; 2012 Oct; 72(4):550-8. PubMed ID: 23109149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie.
    Imbach T; Schenk B; Schollen E; Burda P; Stutz A; Grunewald S; Bailie NM; King MD; Jaeken J; Matthijs G; Berger EG; Aebi M; Hennet T
    J Clin Invest; 2000 Jan; 105(2):233-9. PubMed ID: 10642602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DPAGT1-CDG: Functional analysis of disease-causing pathogenic mutations and role of endoplasmic reticulum stress.
    Yuste-Checa P; Vega AI; Martín-Higueras C; Medrano C; Gámez A; Desviat LR; Ugarte M; Pérez-Cerdá C; Pérez B
    PLoS One; 2017; 12(6):e0179456. PubMed ID: 28662078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL.
    Frank CG; Grubenmann CE; Eyaid W; Berger EG; Aebi M; Hennet T
    Am J Hum Genet; 2004 Jul; 75(1):146-50. PubMed ID: 15148656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DPAGT1-CDG: Report of Two New Pediatric Patients and Brief Review of the Literature.
    Özsoy Ö; Cinleti T; Günay Ç; Sarıkaya Uzan G; Yeşilmen MC; Lochmüller H; Horvath R; Yiş U; Oktay Y; Hiz Kurul S
    Mol Syndromol; 2023 Aug; 14(4):322-330. PubMed ID: 37766827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life with too much polyprenol: polyprenol reductase deficiency.
    Gründahl JE; Guan Z; Rust S; Reunert J; Müller B; Du Chesne I; Zerres K; Rudnik-Schöneborn S; Ortiz-Brüchle N; Häusler MG; Siedlecka J; Swiezewska E; Raetz CR; Marquardt T
    Mol Genet Metab; 2012 Apr; 105(4):642-51. PubMed ID: 22304929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further Delineation of the Phenotype of Congenital Disorder of Glycosylation DPAGT1-CDG (CDG-Ij) Identified by Homozygosity Mapping.
    Imtiaz F; Al-Mostafa A; Al-Hassnan ZN
    JIMD Rep; 2012; 2():107-11. PubMed ID: 23430862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing.
    Timal S; Hoischen A; Lehle L; Adamowicz M; Huijben K; Sykut-Cegielska J; Paprocka J; Jamroz E; van Spronsen FJ; Körner C; Gilissen C; Rodenburg RJ; Eidhof I; Van den Heuvel L; Thiel C; Wevers RA; Morava E; Veltman J; Lefeber DJ
    Hum Mol Genet; 2012 Oct; 21(19):4151-61. PubMed ID: 22492991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel ALG8 mutations expand the clinical spectrum of congenital disorder of glycosylation type Ih.
    Stölting T; Omran H; Erlekotte A; Denecke J; Reunert J; Marquardt T
    Mol Genet Metab; 2009 Nov; 98(3):305-9. PubMed ID: 19648040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A compound heterozygous mutation in DPAGT1 results in a congenital disorder of glycosylation with a relatively mild phenotype.
    Iqbal Z; Shahzad M; Vissers LE; van Scherpenzeel M; Gilissen C; Razzaq A; Zahoor MY; Khan SN; Kleefstra T; Veltman JA; de Brouwer AP; Lefeber DJ; van Bokhoven H; Riazuddin S
    Eur J Hum Genet; 2013 Aug; 21(8):844-9. PubMed ID: 23249953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanosine diphosphate-mannose:GlcNAc2-PP-dolichol mannosyltransferase deficiency (congenital disorders of glycosylation type Ik): five new patients and seven novel mutations.
    Dupré T; Vuillaumier-Barrot S; Chantret I; Sadou Yayé H; Le Bizec C; Afenjar A; Altuzarra C; Barnérias C; Burglen L; de Lonlay P; Feillet F; Napuri S; Seta N; Moore SE
    J Med Genet; 2010 Nov; 47(11):729-35. PubMed ID: 20679665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new intronic mutation in the DPM1 gene is associated with a milder form of CDG Ie in two French siblings.
    Dancourt J; Vuillaumier-Barrot S; de Baulny HO; Sfaello I; Barnier A; le Bizec C; Dupre T; Durand G; Seta N; Moore SE
    Pediatr Res; 2006 Jun; 59(6):835-9. PubMed ID: 16641202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dolichol kinase deficiency (DOLK-CDG) with a purely neurological presentation caused by a novel mutation.
    Helander A; Stödberg T; Jaeken J; Matthijs G; Eriksson M; Eggertsen G
    Mol Genet Metab; 2013 Nov; 110(3):342-4. PubMed ID: 23890587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved diagnostics lead to identification of three new patients with congenital disorder of glycosylation-Ip.
    Thiel C; Rind N; Popovici D; Hoffmann GF; Hanson K; Conway RL; Adamski CR; Butler E; Scanlon R; Lambert M; Apeshiotis N; Thiels C; Matthijs G; Körner C
    Hum Mutat; 2012 Mar; 33(3):485-7. PubMed ID: 22213132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SRD5A3-CDG: a patient with a novel mutation.
    Kasapkara CS; Tümer L; Ezgü FS; Hasanoğlu A; Race V; Matthijs G; Jaeken J
    Eur J Paediatr Neurol; 2012 Sep; 16(5):554-6. PubMed ID: 22240719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of fatal Type I congenital disorders of glycosylation (CDG I) associated with low dehydrodolichol diphosphate synthase (DHDDS) activity.
    Sabry S; Vuillaumier-Barrot S; Mintet E; Fasseu M; Valayannopoulos V; Héron D; Dorison N; Mignot C; Seta N; Chantret I; Dupré T; Moore SE
    Orphanet J Rare Dis; 2016 Jun; 11(1):84. PubMed ID: 27343064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If.
    Schenk B; Imbach T; Frank CG; Grubenmann CE; Raymond GV; Hurvitz H; Korn-Lubetzki I; Revel-Vik S; Raas-Rotschild A; Luder AS; Jaeken J; Berger EG; Matthijs G; Hennet T; Aebi M
    J Clin Invest; 2001 Dec; 108(11):1687-95. PubMed ID: 11733564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.